- Home
- About ASF
- What is Autism?
- How Common is Autism?
- Signs and Symptoms of Autism
- Autism Diagnosis
- Following a Diagnosis
- Treatment Options
- Beware of Non-Evidence-Based Treatments
- Statement on Use of Medical Marijuana for People with Autism
- Autism and Vaccines
- Autism Science
- Quick Facts About Autism
- What We Fund
- Get Involved
- Resources
- COVID-19 Resources
- Day of Learning
- Contact Us
DSM5 – where are we now?
Published July 1, 2019
in ASF Pocast
Don’t be fooled, not all the studies on this week’s podcast focus on the DSM5. But the first one, a review of a meta analysis and review of the dozens of publications that have emerged in the past 5 years around the DSM5 leads us off. There are some people that weren’t captured by either DSM5 or Social Communication Disorder that need a diagnosis, and that should be the focus of future research. A new topic of diagnosis is also explored by a large collaboration is addressed: diagnosis in cousins. They do show a higher probability of an autism diagnosis, but not as high as first degree siblings. Finally, a new tool called JAKE in monitoring treatment effectiveness is presented. This could be used not just in the clinic but at home. It includes monitoring of biological and behavioral features, and might be the next big thing in outcomes for treatment studies.
https://asfpodcast.org/archives/722
Filed under: Autism Research, Autism Science, broader autism phenotype, DSM, epidemiology, podcast, risk, Siblings